IP Library › Granted Patent US 9,561,193
Granted Patent B2
US 9,561,193 · App. 14/343,940 · Granted Feb 7, 2017

Oral and skin care compositions based on a 3,3-Dialkyl-1,1-biphenyl-2,2-diol or a 3,3-Dialkenyl-1,1-biphenyl-2,2-diol

Inventors: Ravi Subramanyam (Belle Mead, NJ); Neelima Utgikar (Maharashtra, IN); Guofeng Xu (Plainsboro, NJ); Ying Yang (Monmouth Junction, NJ); Lin Fei (Kendall Park, NJ)
Assignee: Colgate-Palmolive Company
A61K31/05A61K8/347A61Q11/00A61Q17/005A61Q19/10A61K2800/5922A61Q15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,561,193
App. No.
14/343,940
Granted
Feb 7, 2017
Kind
B2
Abstract

Described herein are compositions comprising antibacterially effective amounts of a compound of Formula (I): or a salt thereof in which R1 and R2 are each independently (C1-C6) alkyl or (C2 C6) alkenyl, and a carrier. Suitable carriers include orally acceptable carriers and dermatologically acceptable carriers. The disclosed compositions include oral care and personal care compositions useful for treating or preventing oral and skin conditions, respectively.

Claims (23)

1. An oral care composition comprising

an antibacterially-effective amount of a compound of Formula (I)

having the following structure:

and an orally-acceptable carrier.

2. The oral care composition of claim 1 , wherein the compound of Formula (I) is present at a concentration of from about 0.001% to about 10%, by weight.

3. The oral care composition of claim 1 , wherein the compound of Formula (I) is present at a concentration of from about 0.01% to about 5%, by weight.

4. The oral care composition of claim 1 , wherein the compound of Formula (I) is present at a concentration of from about 0.1% to about 2.5%, by weight.

5. The oral care composition of claim 1 , further comprising an active agent selected from the group consisting of magnolol, tetrahydromagnolol, butyl magnolol, honokiol, tetrahydrohonokiol, triclosan, delmopinol, cetyl pyridinium chloride, a zinc ion source, a stannous ion source, an anti-inflammatory agent, a botanical agent, and a combination of two or more thereof.

6. The oral care composition of claim 1 , wherein the oral care composition is selected from the group consisting of a tooth paste, a gel, a mousse, a powder, a confectionary, a strip, an oral spray and a mouth rinse.

7. The oral care composition of claim 1 , wherein the oral care composition is a tooth paste comprising a component selected from the group consisting of a humectant, an abrasive, a fluoride ion source, an anticalculus agent, a buffering agent, a thickener, a cleaning agent, a whitener, and a combination of two or more thereof.

8. The oral care composition of claim 7 , wherein the fluoride ion source is selected from the group consisting of stannous fluoride, sodium fluoride, potassium fluoride, sodium monofluorophosphate, sodium fluorosilicate, ammonium fluorosilicate, amine fluoride, ammonium fluoride, and a combination of two or more thereof.

9. The oral care composition of claim 7 , wherein the anticalculus agent is selected from the group consisting of tetrasodium pyrophosphate, trisodium pyrophosphate, a synthetic anionic polycarboxylate, and a combination of two or more thereof.

10. The oral care composition of claim 7 , wherein the abrasive is an amorphous silica abrasive.

11. The oral care composition of claim 7 , wherein the thickener is an amorphous silica thickener.

12. The oral care composition of claim 7 , wherein the cleaning agent is a high cleaning silica.

13. A method for inhibiting bacterial growth in an oral cavity of a subject in need thereof, the method comprising contacting an oral cavity surface of the subject with a composition comprising a compound of formula (I)

having the following structure:

14. A personal care composition comprising an antibacterially-effective amount of a compound of formula (I)

having the following structure:

and a dermatologically-acceptable carrier.

15. A method of treating a skin condition in a subject in

need thereof, comprising contacting the skin of the subject with the composition of claim 14 .

16. The method of claim 15 , wherein the condition is selected from the group consisting of body odor, eryhthrasma, acne, impetigo, boils, folliculitis, cellulitis, carbuncles, and scalded skin syndrome.

Continuity (1)
Related Publication 20140234232A1 · Aug 21, 2014